Document:

Exhibit
10.1

 

NEITHER
THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR
(B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY
OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

 

EKIMAS
CORPORATION

 

WARRANT
TO PURCHASE COMMON STOCK

 

	Warrant
  No. W-1	Original
  Issue Date: April 1, 2022

 

EKIMAS
CORPORATION, a Delaware corporation (the “Company”), hereby certifies that, for value received, GK
Partners ApS or its permitted registered assigns (the “Holder”), is entitled to purchase from the
Company up to a total of 6,000,000 shares of common stock, $0.001 par value per share (the “Common Stock”), of the
Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise
price per share equal to $1.00 (as adjusted from time to time as provided in Section 9 herein, the “Exercise Price”),
at any time and from time to time on or after the Original Issue Date and through and including 5:00 P.M., New York City time, on December
31, 2023 (the “Expiration Date”), subject to the following terms and conditions:

 

1.
Definitions. In addition to the terms defined elsewhere in this warrant (this “Warrant”), capitalized terms
that are not otherwise defined herein have the meanings given to such terms in the Regulation S Subscription Agreement dated on or about
the date of this Agreement between the Company and Holder (the “Subscription Agreement”).

 

2.
Registration of Warrants on Company’s Books. The Company shall register this Warrant, upon records to be maintained by
the Company for that purpose (the “Warrant Register”), in the name of the record Holder (which shall include the initial
Holder or, as the case may be, any registered assignee to which this Warrant is permissibly assigned hereunder) from time to time. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof
or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

    	 

     

    

 

3.
Registration of Transfers. Subject to the restrictions on transfer set forth in Article III of the Subscription Agreement and
compliance with all applicable securities laws, the Company shall register the transfer of all or any portion of this Warrant in the
Warrant Register, upon (i) surrender of this Warrant, with the Form of Assignment attached as Schedule 2 hereto duly completed
and signed, to the Company at its address specified in the Subscription Agreement and (ii) if the Registration Statement is not effective,
(x) delivery, at the request of the Company, of an opinion of counsel reasonably satisfactory to the Company to the effect that the transfer
of such portion of this Warrant may be made pursuant to an available exemption from the registration requirements of the Securities Act
and all applicable state securities or blue sky laws and (y) delivery by the transferee of a written statement to the Company certifying
that the transferee is an “accredited investor” as defined in Rule 501(a) under the Securities Act and making the representations
and certifications set forth in Article IV of the Subscription Agreement, to the Company at its address specified in the Subscription
Agreement. Upon any such registration or transfer, a new warrant to purchase Common Stock in substantially the form of this Warrant (any
such new warrant, a “New Warrant”) evidencing the portion of this Warrant so transferred shall be issued to the transferee,
and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder.
The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and
obligations of a Holder of a Warrant. Notwithstanding the foregoing, this Warrant may not be transferred in increments of less than 10,000
Warrant Shares unless the entire remaining Warrant is transferred.

 

4.
Exercise and Duration of Warrants.

 

(a)
All or any part of this Warrant shall be exercisable, in whole or in part, by the registered Holder at any time and from time to time
on or after the Original Issue Date and through and including 5:00 P.M., New York City time, on the Expiration Date. At 5:00 P.M., New
York City time, on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no value
and this Warrant shall be terminated and no longer outstanding.

 

(b)
The Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as Schedule 1 hereto (the
“Exercise Notice”), appropriately completed and duly signed and (ii) payment in immediately available funds of the
Exercise Price for the number of Warrant Shares as to which this Warrant is being exercised, and the date such items are delivered to
the Company (as determined in accordance with the notice provisions hereof) is an “Exercise Date.” The delivery by (or on
behalf of) the Holder of the Exercise Notice and the applicable Exercise Price as provided above shall constitute the Holder’s
certification to the Company that its representations contained in Article IV of the Subscription Agreement are true and correct as of
the Exercise Date as if remade in their entirety (or, in the case of any transferee Holder that is not a party to the Subscription Agreement,
such transferee Holder’s certification to the Company that such representations are true and correct as to such assignee Holder
as of the Exercise Date). The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder.
Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New
Warrant evidencing the right to purchase the remaining number of Warrant Shares.

 

    	2

     

    

 

5.
Delivery of Warrant Shares.

 

(a)
Upon exercise of this Warrant, the Company shall promptly (but in no event later than three Trading Days after the Exercise Date) issue
or cause to be issued and cause to be delivered to or upon the written order of the Holder and in such name or names as the Holder may
designate (provided that, if the Registration Statement is not effective and the Holder directs the Company to register the Warrant Shares
in a name other than that of the Holder, it shall deliver to the Company on the Exercise Date an opinion of counsel reasonably satisfactory
to the Company to the effect that the issuance of such Warrant Shares in such other name may be made pursuant to an available exemption
from the registration requirements of the Securities Act and all applicable state securities or blue sky laws), a certificate for the
Warrant Shares issuable upon such exercise, free of restrictive legends, unless a registration statement covering the resale of the Warrant
Shares and naming the Holder as a selling stockholder thereunder is not then effective or the Warrant Shares are not freely transferable
without volume restrictions pursuant to Rule 144 under the Securities Act. The Holder, or any Person permissibly so designated by the
Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date.
If the Warrant Shares are to be issued free of all restrictive legends, the Company shall, upon the written request of the Holder, use
its commercially reasonable efforts to deliver, or cause to be delivered, Warrant Shares hereunder electronically through The Depository
Trust Company or another established clearing corporation performing similar functions, if available; provided, that, the
Company may, but will not be required to, change its transfer agent if its current transfer agent cannot deliver Warrant Shares electronically
through such a clearing corporation.

 

(b)
To the extent permitted by law, the Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof
are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with
respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company
or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might
otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing herein shall
limit the Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver Common Stock
upon exercise of this Warrant as required pursuant to the terms hereof.

 

6.
Charges, Taxes and Expenses. Issuance and delivery of certificates for shares of Common Stock upon exercise of this Warrant shall
be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense in respect
of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however, that the
Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates
for Warrant Shares or Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all
other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.

 

    	3

     

    

 

7.
Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be
issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New
Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case)
and, in each case, a customary and reasonable indemnity (which shall not include a surety bond), if requested. Applicants for a New
Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other
reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this
Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company’s
obligation to issue the New Warrant.

 

8.
Reservation of Warrant Shares. The Company covenants that it will reserve and keep available out of the aggregate of its authorized
but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this
Warrant as herein provided, one hundred percent (100%) of the number of Warrant Shares which are initially issuable and deliverable upon
the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder
(taking into account the adjustments and restrictions of Section 9). The Company covenants that all Warrant Shares so issuable and deliverable
shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized,
issued and fully paid and nonassessable. The Company will take all such action as may be necessary to assure that such shares of Common
Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any securities
exchange or automated quotation system upon which the Common Stock may be listed.

 

9.
Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 9.

 

(a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common
Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides its
outstanding shares of Common Stock into a larger number of shares, or (iii) combines its outstanding shares of Common Stock into a smaller
number of shares, then in each such case the Exercise Price shall be multiplied by a fraction, the numerator of which shall be the number
of shares of Common Stock outstanding immediately before such event and the denominator of which shall be the number of shares of Common
Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant
to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.

 

(b)
Pro Rata Distributions. If the Company, at any time while this Warrant is outstanding, distributes to all holders of Common Stock
(i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Stock covered by the preceding paragraph),
(iii) rights or warrants to subscribe for or purchase any security, or (iv) any other asset (in each case, “Distributed Property”),
then, upon any exercise of this Warrant that occurs after the record date fixed for determination of stockholders entitled to receive
such distribution, the Holder shall be entitled to receive, in addition to the Warrant Shares otherwise issuable upon such exercise (if
applicable), the Distributed Property that such Holder would have been entitled to receive in respect of such number of Warrant Shares
had the Holder been the record holder of such Warrant Shares immediately prior to such record date.

 

    	4

     

    

 

(c)
Fundamental Transactions. If, at any time while this Warrant is outstanding (i) the Company effects any merger or consolidation
of the Company with or into another Person, in which the Company is not the survivor and the stockholders of the Company immediately
prior to such merger or consolidation do not own, directly or indirectly, at least fifty percent (50%) of the voting securities of the
surviving entity, (ii) the Company effects any sale of all or substantially all of its assets or a majority of its Common Stock is acquired
by a third party, in each case, in one or a series of related transactions, (iii) any tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which all or substantially all of the holders of Common Stock are permitted to tender
or exchange their shares for other securities, cash or property, or (iv) the Company effects any reclassification of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by Section 9(a) above) (in
any such case, a “Fundamental Transaction”), then the Holder shall thereafter receive, upon exercise of this Warrant,
in lieu of any Warrant Shares, the same amount and kind of securities, cash or property as it would have been entitled to receive upon
the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number
of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any limitations on exercise contained herein
(the “Alternate Consideration”). The Company shall not effect any such Fundamental Transaction unless prior to or
simultaneously with the consummation thereof, any successor to the Company, surviving entity or the corporation purchasing or otherwise
acquiring such assets or other appropriate corporation or entity shall assume the obligation to deliver to the Holder, such Alternate
Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to purchase and/or receive (as the case may
be), and the other obligations under this Warrant. The provisions of this paragraph (c) shall similarly apply to subsequent transactions
analogous to a Fundamental Transaction.

 

(d)
Subsequent Equity Sales. If the Company at any time while this Warrant is outstanding, shall sell or grant any option to purchase,
or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase
or other disposition) any Common Stock or any securities of the Company which would entitle the holder thereof to acquire at any time
Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time
convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock (“Common
Stock Equivalents”), at an effective price per share less than the Exercise Price then in effect (such lower price, the “Base
Share Price” and such issuances collectively, a “Dilutive Issuance”) (it being understood and agreed that
if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments,
reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which
are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less
than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive
Issuance at such effective price), then simultaneously with the consummation of each Dilutive Issuance the Exercise Price shall be reduced
and only reduced to equal the Base Share Price and the number of Warrant Shares issuable hereunder shall be increased such that the aggregate
Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise
Price prior to such adjustment. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding
the foregoing, no adjustments shall be made, paid or issued under this Section 9(d) in respect of an Exempt Issuance. “Exempt
Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers, directors or consultants (provided
that such issuances to consultant shall not exceed $500,000 of shares in any 12-month period) of the Company pursuant to any stock or
option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members
of a committee of non-employee directors established for such purpose, (b) securities upon the exercise or exchange of or conversion
of any Warrants or Warrant Shares issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares
of Common Stock issued and outstanding on the date of this Warrant, provided that such securities have not been amended since the date
of this Warrant to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such
securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that any such issuance shall only be to a person or entity (or to the equityholders of a person or
entity) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the
business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include
a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business
is investing in securities.

 

    	5

     

    

 

(e)
The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common
Stock or Common Stock Equivalents subject to this Section 9(d), indicating therein the applicable issuance price, or applicable reset
price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”). For
purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 9(d), upon the occurrence
of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price regardless of
whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. Notwithstanding anything herein to the contrary,
this Section 9(d) shall terminate and be of no further force or effect after six months after the date that all of the Warrant Shares
are freely tradable under Rule 144 without the requirement to be in compliance with the current public information requirements thereunder.

 

(f)
Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a) and (e) of this Section,
the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so
that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased number of Warrant Shares shall
be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.

(g)
Calculations. All calculations under this Section 9 shall be made to the nearest cent or the nearest share, as applicable. The
number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company,
and the sale or issuance of any such shares shall be considered an issue or sale of Common Stock.

 

(h)
Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will, at
the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and
prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type
of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise
to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly
deliver a copy of each such certificate to the Holder and to the Company’s transfer agent.

 

(i)
  Notice of Corporate Events. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution
of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants
to subscribe for or purchase any capital stock of the Company or any subsidiary, (ii) authorizes or approves, enters into any agreement
contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation
or winding up of the affairs of the Company, then, except if such notice and the contents thereof shall be deemed to constitute material
non-public information, the Company shall deliver to the Holder a notice describing the material terms and conditions of such transaction
at least ten (10) Trading Days prior to the applicable record or effective date on which a Person would need to hold Common Stock in
order to participate in or vote with respect to such transaction, and the Company will take all steps reasonably necessary in order to
ensure that the Holder is given the practical opportunity to exercise this Warrant prior to such time so as to participate in or vote
with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect
the validity of the corporate action required to be described in such notice.

 

10.
Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds.

 

11.
No Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of
any fractional shares which would, otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next
whole number and the Company shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional
shares.

 

    	6

     

    

 

12.
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder (including,
without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date
of transmission, if such notice or communication is delivered via facsimile (provided the sender receives a machine generated confirmation
of successful transmission) at the facsimile number specified in the Subscription Agreement prior to 5:00 P.M., New York City time, on
a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at
the facsimile number specified in the Subscription Agreement on a day that is not a Trading Day or later than 5:00 P.M., New York City
time, on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service
specifying next business day delivery, or (iv) upon actual receipt by the party to whom such notice is required to be given, if by hand
delivery. The address and facsimile number of a party for such notices or communications shall be as set forth in the Subscription Agreement
unless changed by such party by two Trading Days’ prior notice to the other party in accordance with this Section 12.

 

13.
Warrant Agent. The Company shall serve as warrant agent under this Warrant. Upon thirty (30) days’ notice to the Holder,
the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation
resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company
or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant
agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant
agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register.

 

14.
Miscellaneous.

 

(a)
No Rights as a Shareholder. The Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled
to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in
this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the
rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization,
issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is
then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as
imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of
the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 14(a),
the Company shall provide the Holder with copies of the same notices and other information given to the shareholders of the Company,
contemporaneously with the giving thereof to the shareholders.

 

(b)
Successors and Assigns. Subject to the restrictions on transfer set forth in this Warrant and in Section 4.1 of the Subscription
Agreement, and compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned
by the Company except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on and inure to the benefit
of the parties hereto and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be
construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this
Warrant. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns.

 

(c)
Governing Law; Jurisdiction. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS
WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES
OF CONFLICTS OF LAW THEREOF. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING
IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION
CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY
WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF
ANY SUCH COURT. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT,
ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO
SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THE SUBSCRIPTION AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE
GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO
SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH PARTY HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.

 

(d)
Headings. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit
or affect any of the provisions hereof.

 

(e)
Severability. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the
validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby,
and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute
therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.

 

	 	EKIMAS
  CORPORATION
	 	 	 
	 	By:	/s/
  Bennett J. Yankowitz
	 	 	Bennett
  J. Yankowitz
			Chief Executive Officer

 

    	7

     

    

 

SCHEDULE
1

 

FORM
OF EXERCISE NOTICE

 

(To
be executed by the Holder to purchase shares of Common Stock under the foregoing Warrant)

 

Ladies
and Gentlemen:

 

The
undersigned is the Holder of Warrant No.W-1 (the “Warrant”) issued by EKIMAS Corporation, a Delaware corporation (the
“Company”). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth
in the Warrant.

 

The
undersigned hereby exercises its right to purchase __________ Warrant Shares pursuant to the Warrant.

 

Pursuant
to this Exercise Notice, the Company shall deliver to the Holder _____________ Warrant Shares in accordance with the terms of the Warrant.

 

	Dated:	 	 
	 	 	 
	Name
    of Holder:  	 	 
	 	 	 
	By:	 	 
	 	 	 
	Name:  	 	 
	 	 	 
	Title:  	 	 

 

(Signature
must conform in all respects to name of Holder as specified on the face of the Warrant)

 

 

    	8

     

    

 

SCHEDULE
2 

 

EKIMAS
CORPORATION

 

FORM
OF ASSIGNMENT

 

[To
be completed and signed only upon transfer of Warrant]

 

FOR
VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto _______________ (the “Transferee”) the right
represented by the within Warrant to purchase ___________ shares of Common Stock of EKIMAS Corporation (the “Company”)
to which the within Warrant relates and appoints ___________________ attorney to transfer said right on the books of the Company with
full power of substitution in the premises. In connection therewith, the undersigned represents, warrants, covenants and agrees to and
with the Company that:

 

(a)
the offer and sale of the Warrant contemplated hereby is being made in compliance with Section 4(1) of the United States Securities Act
of 1933, as amended (the “Securities Act”) or another valid exemption from the registration requirements of Section
5 of the Securities Act and in compliance with all applicable securities laws of the states of the United States;

 

(b)
the undersigned has not offered to sell the Warrant by any form of general solicitation or general advertising, including, but not limited
to, any advertisement, article, notice or other communication published in any newspaper, magazine or similar media or broadcast over
television or radio, and any seminar or meeting whose attendees have been invited by any general solicitation or general advertising;

 

(c)
the undersigned has read the Transferee’s investment letter included herewith, and to its actual knowledge, the statements made
therein are true and correct; and

 

(d)
the undersigned understands that the Company may condition the transfer of the Warrant contemplated hereby upon the delivery to the Company
by the undersigned or the Transferee, as the case may be, of a written opinion of counsel (which opinion shall be in form, substance
and scope customary for opinions of counsel in comparable transactions) to the effect that such transfer may be made without registration
under the Securities Act and under applicable securities laws of the states of the United States.

 

	Dated:
    	 	 	 
	 	 	 	 
	 	 	 	(Signature
    must conform in all respects to name of holder as specified on the face of the Warrant)
	 	 	 	 
	 	 	 	 
	 	 	 	Address
    of Transferee
	 	 	 	 
	 	 	 	 
	In
    the presence of:	 	 
	 	 	 
	 	 	 

 

    	9Exhibit
4.5

 

Description
of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended

 

The
following description sets forth certain material terms and provisions of the securities of Finnovate Acquisition Corp (“we,”
“us” or “our”) that are registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”). The following description of our securities is not complete and may not contain all the information you should consider
before investing in our securities. This description is summarized from, and qualified in its entirety by reference to, our amended and
restated memorandum and articles of association, which are incorporated herein by reference. The summary below is also qualified by reference
to the Companies Act (As Revised) (the “Companies Act”) and common law of the Cayman Islands.

 

As
of November 8, 2021, we had three classes of securities registered under the Exchange Act: our Class A ordinary shares, $0.0001 par value
per share; warrants to purchase shares of our Class A ordinary shares; and units consisting of one Class A ordinary share and three-quarters
of a redeemable warrant to purchase one Class A ordinary share. In addition, this Description of Securities also contains a description
of our founders shares, par value $0.0001 per share (“founders shares”), which are not registered pursuant to Section 12
of the Exchange Act but are convertible into Class A ordinary shares. The description of the founders shares is necessary to understand
the material terms of the Class A ordinary shares.

 

Units

 

Each
unit consists of one Class A ordinary share and three-quarters of one warrant. Each whole warrant entitles the holder thereof to purchase
one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described elsewhere in this Exhibit. Pursuant to
the Warrant Agreement (as defined herein), a warrant holder may exercise its warrants only for a whole number of Class A ordinary shares.
This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon
separation of the units and only whole warrants will trade. Accordingly, unless you own at least two units, you will not be able to receive
or trade a whole warrant and if you own units in multiples of less than four, you will lose a fraction of a warrant.

 

The
Class A ordinary shares and warrants began to trade separately on December 8, 2021, upon which unit holders may elect to continue to
hold units or to separate their units into the component pieces.

 

Ordinary
Shares

 

Class
A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be
voted on by shareholders, except as required by law; provided that, prior to our initial business combination, only holders of our Class
B ordinary shares will have the right to vote on the appointment of directors, and holders of a majority of our Class B ordinary shares
may remove a member of the board of directors for any reason. With respect to any other matter submitted to a vote of our shareholders,
including any vote in connection with our initial business combination, except as required by law, holders of Class A ordinary shares
and holders of Class B ordinary shares will vote together as a single class. Unless specified in the Companies Act, our amended and restated
memorandum and articles of association or applicable stock exchange rules, the affirmative vote of a majority of our shares that are
voted is required to approve any matter voted on by our shareholders. Approval of certain actions will require a special resolution under
Cayman Islands law and pursuant to our amended and restated memorandum and articles of association; such actions include amending our
amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. Directors
are appointed for a term of two years. There is no cumulative voting with respect to the appointment of directors, with the result that
the holders of more than 50% of the founders shares purchased prior to our initial public offering that are voted for the appointment
of directors can appoint all of the directors prior to our initial business combination. Our shareholders are entitled to receive ratable
dividends when, as and if declared by the board of directors out of funds legally available therefor.

 

Because
our amended and restated memorandum and articles of association authorize the issuance of up to 500,000,000 Class A ordinary shares,
if we were to enter into a business combination, we may (depending on the terms of such a business combination) be required to increase
the number of Class A ordinary shares which we are authorized to issue at the same time as our shareholders vote on the business combination
to the extent we seek shareholder approval in connection with our initial business combination.

 

In
accordance with Nasdaq corporate governance requirements, we are required to hold an annual general meeting no later than one year after
our first fiscal year end following our listing on the Nasdaq. There is no requirement under the Companies Act or our amended and restated
memorandum and articles of association for us to hold annual general meetings in order to elect directors. Consequently, because the
term of our directors elected prior to our initial public offering is for two years, we will not be re-electing directors at our initial
annual general meeting held following our initial public offering. It is also possible that we may not hold an annual general meeting
prior to the consummation of our initial business combination. Our amended and restated memorandum and articles of association furthermore
provide that only our board of directors—and not our shareholders—have the right to call a general meeting of shareholders.

 

    	 

     

    

 

We
will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our
initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account
as of two business days prior to the consummation of our initial business combination, including accrued interest (which interest shall
be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to the limitations described herein.
At the completion of our initial business combination, we will be required to purchase any Class A ordinary shares properly delivered
for redemption and not withdrawn. Following our initial public offering, the amount in the trust account was initially $10.20 per public
share. Additionally, each public shareholder may elect to redeem its public shares without voting and, if they do vote, irrespective
of whether they vote for or against the proposed business combination. Our initial shareholders have entered into a letter agreement
with us, pursuant to which they have agreed to waive their redemption rights with respect to their founders shares and any public shares
held by them in connection with the completion of our initial business combination. Our directors and officers have also entered into
the letter agreement, imposing similar obligations on them with respect to public shares acquired by them, if any. Permitted transferees
of our initial shareholders, officers or directors will be subject to the same obligations.

 

If
we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public
shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as
a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to
more than an aggregate of 15% of the ordinary shares sold in our initial public offering, which we refer to as the “Excess Shares,”
without our prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including
Excess Shares) for or against our initial business combination. Our shareholders’ inability to redeem the Excess Shares will reduce
their influence over our ability to complete our initial business combination, and those shareholders could suffer a material loss in
their investment if they sell their Excess Shares on the open market. Additionally, those shareholders will not receive redemption distributions
with respect to the Excess Shares if we complete the business combination. As a result, those shareholders will continue to hold that
number of shares exceeding 15% and, in order to dispose of those shares, would be required to sell their shares in open market transactions,
potentially at a loss.

 

If
we seek shareholder approval in connection with our initial business combination, our initial shareholders have (and their permitted
transferees will agree), pursuant to the terms of a letter agreement entered into with us, and EarlyBirdCapital has, pursuant to the
underwriting agreement relating to our initial public offering (the “Underwriting Agreement”), agreed to vote their founders
shares and EBC founder shares, respectively, and any public shares held by them in favor of our initial business combination. Our amended
and restated articles of association and memorandum provide that any of the their provisions, including those related to pre-business
combination activity, may be amended if approved by holders of at least two-thirds of our ordinary shares who, as being entitled to do
so, attend and vote in person or, where proxies are allowed, by proxy in a general meeting. As a result, if we need to amend our amended
and restated articles of association and memorandum in order to effectuate our initial business combination, in addition to our sponsor’s
founder shares and EarlyBirdCapital’s EBC founder shares, we would need 10,084,875, or 58.46%, of the 17,250,000 public shares
sold in our initial public offering to be voted in favor of a transaction (assuming all issued and outstanding shares are voted), subject
to any higher threshold as is required by Cayman Islands or other applicable law. Our directors and officers have also entered into the
letter agreement, imposing similar obligations on them with respect to public shares acquired by them, if any.

 

Our
amended and restated memorandum and articles of association provide that if we are unable to complete our initial business combination
within 18 months from the closing of this offering, we will (1) cease all operations except for the purpose of winding up, (2) as promptly
as reasonably possible but not more than 10 business days thereafter, subject to funds lawfully available therefor, redeem 100% of the
public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including accrued
interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the
number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as
shareholders (including the right to receive further liquidating distributions, if any) and (3) as promptly as reasonably possible following
such redemption, subject to the approval of our remaining shareholders and our board of directors, dissolve and liquidate, subject in
each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
Our initial shareholders have entered into a letter agreement with us, pursuant to which they have agreed to waive their rights to liquidating
distributions from the trust account with respect to their founders shares if we fail to complete our initial business combination within
18 months from the closing of our initial public offering. However, if our initial shareholders acquire public shares after our initial
public offering, they will be entitled to liquidating distributions from the trust account with respect to those public shares if we
fail to complete our initial business combination within the prescribed time period.

 

    	2

     

    

 

In
the event of a liquidation, dissolution or winding up of the company after a business combination, our shareholders at such time will
be entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision
is made for each class of shares, if any, having preference over the ordinary shares. Our shareholders have no preemptive or other subscription
rights. There are no sinking fund provisions applicable to the ordinary shares, except that we will provide our shareholders with the
opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust
account, including accrued interest (which interest shall be net of taxes payable), upon the completion of our initial business combination,
subject to the limitations described herein.

 

Founders
Shares

 

The
founders shares are designated as Class B ordinary shares and are identical to the Class A ordinary shares included in the units being
sold in our initial public offering, and holders of founders shares have the same shareholder rights as public shareholders, except that:
(1) prior to our initial business combination, only holders of the founders shares have the right to vote on the appointment of directors
and holders of a majority of our founders shares may remove a member of the board of directors for any reason; (2) the founders shares
are subject to certain transfer restrictions, as described in more detail below; (3) our sponsor has entered into a letter agreement
with us, pursuant to which it has agreed to waive: (x) its redemption rights with respect to its founders shares and any public shares
held by it in connection with the completion of our initial business combination (and not seek to sell its shares to us in any tender
offer we undertake in connection with our initial business combination); (y) its redemption rights with respect to its founders shares
and any public shares held by it in connection with a shareholder vote to approve an amendment to our amended and restated memorandum
and articles of association (A) that would affect our public shareholders’ ability to convert or sell their shares to us in connection
with a business combination as described herein or to the redemption rights provided to shareholders if we do not complete our initial
business combination within 18 months from the closing of our initial public offering, as described elsewhere in this Exhibit, or (B)
with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity; and (z) their
rights to liquidating distributions from the trust account with respect to any founders shares they hold if we fail to complete our initial
business combination within 18 months from the closing of our initial public offering (although they will be entitled to liquidating
distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination
within the prescribed time frame); (4) the founders shares will automatically convert into our Class A ordinary shares as described below
and (5) the founders shares are entitled to registration rights. In addition, our directors and officers have also entered into the letter
agreement with respect to public shares acquired by them, if any.

 

The
founders shares will automatically convert into Class A ordinary shares on the first business day following the completion of our initial
business combination on a one-for-one basis, subject to adjustment as provided herein. In the case that additional Class A ordinary shares,
or equity-linked securities convertible or exercisable for Class A ordinary shares, are issued or deemed issued in excess of the amounts
issued in our initial public offering and related to the closing of our initial business combination, the ratio at which founders shares
will convert into Class A ordinary shares will be adjusted (subject to waiver by holders of a majority of the Class B ordinary shares
then in issue) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the
aggregate, on an as-converted basis, 20% of the sum of our ordinary shares issued and outstanding upon the completion of our initial
public offering plus the number of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with our
initial business combination (net of redemptions), excluding the EBC founder shares and any Class A ordinary shares or equity-linked
securities issued, or to be issued, to any seller in our initial business combination and any private warrants issued to our sponsor,
a partner or affiliate of our sponsor, or any of our officers or directors.

 

With
certain limited exceptions, the founders shares are not transferable, assignable or salable (except to our officers and directors and
other persons or entities affiliated with our sponsor, each of whom will be subject to the same transfer restrictions) until 180 days
after the completion of our initial business combination.

 

Furthermore,
all founders shares will also be released from lock-up, if sooner than the above, on the date following the completion of our initial
business combination on which we complete a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction
that results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other
property.

 

    	3

     

    

 

Register
of Members (Shareholders)

 

Under
Cayman Islands law, we must keep a register of members (i.e., shareholders) and there shall be entered therein:

 

		●	the
    names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered
    as paid, on the shares of each member and the voting rights of shares;
	 	 	 
		●	the
    date on which the name of any person was entered on the register as a member; and
	 	 	 
		●	the
    date on which any person ceased to be a member.

 

Under
Cayman Islands law, the register of members of our company is prima facie evidence of the matters set out therein (i.e., the register
of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register
of members shall be deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register
of members. Upon the closing of our initial public public offering, the register of members was immediately updated to reflect the issue
of shares by us. Following the update to our register of members, the shareholders recorded in the register of members are deemed to
have legal title to the shares set against their name. However, there are certain limited circumstances where an application may be made
to a Cayman Islands court for a determination as to whether the register of members reflects the correct legal position. Further, a Cayman
Islands court has the power to order that the register of members maintained by a company should be rectified where it considers that
the register of members does not reflect the correct legal position. If an application for an order for rectification of the register
of members were made in respect of our ordinary shares, the validity of those shares may be subject to re-examination by a Cayman Islands
court.

 

Preferred
Shares

 

Our
amended and restated memorandum and articles of association authorize 5,000,000 preferred shares and provide that preferred shares may
be issued from time to time in one or more series. Our board of directors is authorized to fix the voting rights, if any, designations,
powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions
thereof, applicable to the shares of each series. Our board of directors is able to, without shareholder approval, issue preferred shares
with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and
could have anti-takeover effects. The ability of our board of directors to issue preferred shares without shareholder approval could
have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management. We have no preferred
shares issued and outstanding as of the date hereof. Although we do not currently intend to issue any preferred shares, we cannot assure
you that we will not do so in the future. No preferred shares were issued or registered in our initial public offering.

 

Warrants

 

Each
whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment
as discussed below, at any time commencing 30 days following our initial business combination. However, no warrants will be exercisable
for cash unless our (or another) prospectus relating to such Class A ordinary shares and the registration statement for our initial public
offering of which our (or such other) prospectus forms a part are then current and in effect. Notwithstanding the foregoing, if our (or
such other) prospectus relating to the Class A ordinary shares and the registration statement for our initial public offering of which
our (or such other) prospectus forms a part are not then current and in effect (respectively) within 60 business days following the consummation
of our initial business combination, warrant holders may, beginning at such time, exercise warrants on a cashless basis pursuant to the
exemption provided by Section 3(a)(9) of the Securities Act of 1933 (the “Securities Act”), provided that such exemption
is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless
basis. In the case of a cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of Class
A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the
warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below)
by (y) the fair market value. The “fair market value” for this purpose will mean the average reported last sale price of
the Class A ordinary shares for the 5 trading days ending on the trading day prior to the date of exercise. The warrants will expire
on the fifth anniversary of our completion of an initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption
or liquidation.

 

    	4

     

    

 

The
private warrants, as well as any warrants underlying additional private warrants we issue to our sponsor, officers, directors or their
affiliates in payment of working capital loans made to us, will be identical to the warrants underlying the units.

 

We
may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant

 

	 	●	at
    any time after the warrants become exercisable;
	 	 	 
	 	●	upon
    not less than 30 days’ prior written notice of redemption to each warrant holder;
	 	 	 
	 	●	if,
    and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share
    sub-divisions, share capitalizations, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period
    commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant
    holders; and
	 	 	 
	 	●	if,
    and only if, the registration statement for our initial public offering of which our prospectus forms a part (or another registration
    statement) is then in effect with respect to the Class A ordinary shares underlying such warrants.

 

The
right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. On and
after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder’s
warrant upon surrender of such warrant.

 

The
redemption criteria for our warrants have been established at a price which is intended to provide warrant holders a reasonable premium
to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the warrant exercise
price so that if the share price declines as a result of our redemption call, the redemption will not cause the share price to drop below
the exercise price of the warrants.

 

If
we call the warrants for redemption as described above, our management will have the option to require all holders that wish to exercise
warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the warrants
for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary
shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value”
(defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last
sale price of the Class A ordinary shares for the five trading days ending on the third trading day prior to the date on which the notice
of redemption is sent to the holders of warrants.

 

The
warrants were issued in registered form according to a warrant agreement signed between Continental Stock Transfer & Trust Company,
as warrant agent, and us (the “Warrant Agreement”). The Warrant Agreement provides that the terms of the warrants may be
amended without the consent of any holder to cure any ambiguity or correct any defective provision. The Warrant Agreement requires the
approval, by written consent or vote, of the holders of at least 50% of the then outstanding public warrants in order to make any change
that adversely affects the interests of the registered holders.

 

The
exercise price and number of Class A ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including
in the event of a share capitalization or our recapitalization, reorganization, merger or consolidation. However, the warrants will not
be adjusted for issuances of Class A ordinary shares at a price below their respective exercise prices.

 

In
addition, if (x) we issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with
the closing of our initial business combination at a Newly Issued Price (as defined in the Underwriting Agreement) of less than $9.20
per Class A ordinary share, (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds,
and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business
combination (net of redemptions), and (z) the Market Value (as defined in the Warrant Agreement) is below $9.20 per share, then the exercise
price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the Newly
Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the greater
of (i) the Market Value or (ii) the Newly Issued Price.

 

The
warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant
agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full
payment of the exercise price, by certified or official bank check payable to us, for the number of warrants being exercised. The warrant
holders do not have the rights or privileges of holders of Class A ordinary shares and any voting rights until they exercise their warrants
and receive Class A ordinary shares. After the issuance of Class A ordinary shares upon exercise of the warrants, each holder will be
entitled to one vote for each share held of record on all matters to be voted on by shareholders.

 

    	5

     

    

 

Under
the terms of the Warrant Agreement, we have agreed to use our best efforts to have declared effective a prospectus relating to the Class
A ordinary shares issuable upon exercise of the warrants and keep such prospectus current until the expiration of the warrants. However,
we cannot assure you that we will be able to do so and, if the Class A ordinary shares issuable upon exercise of the warrants are not
registered or exempt from registration, holders will be unable to exercise their warrants.

 

Warrant
holders may elect to be subject to a restriction on the exercise of their warrants such that an electing warrant holder would not be
able to exercise their warrants to the extent that, after giving effect to such exercise, such holder would beneficially own in excess
of 9.8% of the Class A ordinary shares outstanding.

 

No
fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive
a fractional interest in a share, we will, upon exercise, round up to the nearest whole number of Class A ordinary shares to be issued
to the warrant holder.

 

We
have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the
Warrant Agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United
States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will
be the exclusive forum for any such action, proceeding or claim. See “Risk Factors — Our warrant agreement designates the
courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum
for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant
holders to obtain a favorable judicial forum for disputes with our company” in Item 1A of our Annual Report on Form 10-K for the
year ended December 31, 2021. This exclusive forum provision shall not apply to suits brought to enforce a duty or liability created
by the Exchange Act, any other claim for which the federal district courts of the United States of America are the sole and exclusive
forum.

 

Dividends

 

We
have not paid any cash dividends on our Class A ordinary shares to date and do not intend to pay cash dividends prior to the completion
of a business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital
requirements and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent
to a business combination will be within the discretion of our then board of directors. It is the present intention of our board of directors
to retain all earnings, if any, for use in our business operations and, accordingly, our board does not anticipate declaring any dividends
in the foreseeable future.

 

Our
Transfer Agent and Warrant Agent

 

The
transfer agent for our ordinary shares and warrant agent for our warrants is Continental Stock Transfer & Trust Company. We have
agreed to indemnify Continental Stock Transfer & Trust Company in its roles as transfer agent and warrant agent, its agents and each
of its shareholders, directors, officers and employees against all liabilities, including judgments, costs and reasonable counsel fees
that may arise out of acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence,
willful misconduct or bad faith of the indemnified person or entity.

 

Certain
Differences in Corporate Law

 

Cayman
Islands companies are governed by the Companies Act. The Companies Act is modeled on English Law but does not follow recent English Law
statutory enactments, and differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary
of the material differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated
in the United States and their shareholders.

 

Mergers
and Similar Arrangements. In certain circumstances, the Companies Law allows for mergers or consolidations between two Cayman
Islands companies, or between a Cayman Islands exempted company and a company incorporated in another jurisdiction (provided that is
facilitated by the laws of that other jurisdiction).

 

    	6

     

    

 

Where
the merger or consolidation is between two Cayman Islands companies, the directors of each company must approve a written plan of merger
or consolidation containing certain prescribed information. That plan or merger or consolidation must then be authorized by either (a)
a special resolution (usually a majority of 662/3% in value who attend and vote at a general meeting) of the shareholders
of each company; and (b) such other authorization, if any, as may be specified in such constituent company’s articles of association.
No shareholder resolution is required for a merger between a parent company (i.e., a company that owns at least 90% of the issued shares
of each class in a subsidiary company) and its subsidiary company. The consent of each holder of a fixed or floating security interest
of a constituent company must be obtained, unless the court waives such requirement. If the Cayman Islands Registrar of Companies is
satisfied that the requirements of the Companies Act (which includes certain other formalities) have been complied with, the Registrar
of Companies will register the plan of merger or consolidation.

 

Where
the merger or consolidation involves a foreign company, the procedure is similar, save that with respect to the foreign company, the
directors of the Cayman Islands exempted company are required to make a declaration to the effect that, having made due enquiry, they
are of the opinion that the requirements set out below have been met: (i) that the merger or consolidation is permitted or not prohibited
by the constitutional documents of the foreign company and by the laws of the jurisdiction in which the foreign company is incorporated,
and that those laws and any requirements of those constitutional documents have been or will be complied with; (ii) that no petition
or other similar proceeding has been filed and remains issued and outstanding or order made or resolution adopted to wind up or liquidate
the foreign company in any jurisdictions; (iii) that no receiver, trustee, administrator or other similar person has been appointed in
any jurisdiction and is acting in respect of the foreign company, its affairs or its property or any part thereof; (iv) that no scheme,
order, compromise or other similar arrangement has been entered into or made in any jurisdiction whereby the rights of creditors of the
foreign company are and continue to be suspended or restricted.

 

Where
the surviving company is the Cayman Islands exempted company, the directors of the Cayman Islands exempted company are further required
to make a declaration to the effect that, having made due enquiry, they are of the opinion that the requirements set out below have been
met: (i) that the foreign company is able to pay its debts as they fall due and that the merger or consolidated is bona fide and not
intended to defraud unsecured creditors of the foreign company; (ii) that in respect of the transfer of any security interest granted
by the foreign company to the surviving or consolidated company (a) consent or approval to the transfer has been obtained, released or
waived; (b) the transfer is permitted by and has been approved in accordance with the constitutional documents of the foreign company;
and (c) the laws of the jurisdiction of the foreign company with respect to the transfer have been or will be complied with; (iii) that
the foreign company will, upon the merger or consolidation becoming effective, cease to be incorporated, registered or exist under the
laws of the relevant foreign jurisdiction; and (iv) that there is no other reason why it would be against the public interest to permit
the merger or consolidation.

 

Where
the above procedures are adopted, the Companies Act provides for a right of dissenting shareholders to be paid a payment of the fair
value of his shares upon their dissenting to the merger or consolidation if they follow a prescribed procedure. In essence, that procedure
is as follows (a) the shareholder must give his written objection to the merger or consolidation to the constituent company before the
vote on the merger or consolidation, including a statement that the shareholder proposes to demand payment for his shares if the merger
or consolidation is authorized by the vote; (b) within 20 days following the date on which the merger or consolidation is approved by
the shareholders, the constituent company must give written notice to each shareholder who made a written objection; (c) a shareholder
must within 20 days following receipt of such notice from the constituent company, give the constituent company a written notice of his
intention to dissent including, among other details, a demand for payment of the fair value of his shares; (d) within seven days following
the date of the expiration of the period set out in clause (b) above or seven days following the date on which the plan of merger or
consolidation is filed, whichever is later, the constituent company, the surviving company or the consolidated company must make a written
offer to each dissenting shareholder to purchase his shares at a price that the company determines is the fair value and if the company
and the shareholder agree the price within 30 days following the date on which the offer was made, the company must pay the shareholder
such amount; (e) if the company and the shareholder fail to agree on a price within such 30 day period, within 20 days following the
date on which such 30 day period expires, the company (and any dissenting shareholder) must file a petition with the Cayman Islands Grand
Court to determine the fair value and such petition must be accompanied by a list of the names and addresses of the dissenting shareholders
with whom agreements as to the fair value of their shares have not been reached by the company. At the hearing of that petition, the
court has the power to determine the fair value of the shares together with a fair rate of interest, if any, to be paid by the company
upon the amount determined to be the fair value. Any dissenting shareholder whose name appears on the list filed by the company may participate
fully in all proceedings until the determination of fair value is reached. These rights of a dissenting shareholder are not be available
in certain circumstances, for example, to dissenters holding shares of any class in respect of which an open market exists on a recognized
stock exchange or recognized interdealer quotation system at the relevant date or where the consideration for such shares to be contributed
are shares of any company listed on a national securities exchange or shares of the surviving or consolidated company.

 

    	7

     

    

 

Moreover,
Cayman Islands law also has separate statutory provisions that facilitate the reconstruction or amalgamation of companies in certain
circumstances, schemes of arrangement will generally be more suited for complex mergers or other transactions involving widely held companies,
commonly referred to in the Cayman Islands as a “scheme of arrangement” which may be tantamount to a merger. In the event
that a merger was sought pursuant to a scheme of arrangement (the procedure of which are more rigorous and take longer to complete than
the procedures typically required to consummate a merger in the United States), the arrangement in question must be approved by a majority
in number of each class of shareholders and creditors with whom the arrangement is to be made and who must in addition represent three-fourths
in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy
at an annual general meeting, or an extraordinary general meeting summoned for that purpose. The convening of the meetings and subsequently
the terms of the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder would have the
right to express to the court the view that the transaction should not be approved, the court can be expected to approve the arrangement
if it satisfies itself that:

 

	 	●	we
                                            are not proposing to act illegally or beyond the scope of our corporate authority and the
                                            statutory provisions

    as
    to majority vote have been complied with;

	 	 	 
	 	●	the
    shareholders have been fairly represented at the meeting in question;
	 	 	 
	 	●	the
    arrangement is such as a businessman would reasonably approve; and
	 	 	 
	 	●	the
                                            arrangement is not one that would more properly be sanctioned under some other provision
                                            of the Companies Act or that would amount to a “fraud on the minority.”

 

If
a scheme of arrangement or takeover offer (as described below) is approved, any dissenting shareholder would have no rights comparable
to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of United States corporations, providing
rights to receive payment in cash for the judicially determined value of the shares.

 

Squeeze-out
Provisions. When a takeover offer is made and accepted by holders of 90% of the shares to whom the offer relates is made within
four months, the offeror may, within a two-month period, require the holders of the remaining shares to transfer such shares on the terms
of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed unless there is evidence
of fraud, bad faith, collusion or inequitable treatment of the shareholders.

 

Further,
transactions similar to a merger, reconstruction and/or an amalgamation may in some circumstances be achieved through other means to
these statutory provisions, such as a share capital exchange, asset acquisition or control, through contractual arrangements, of an operating
business.

 

Shareholders’
Suits. Maples and Calder (Cayman) LLP, our Cayman Islands legal counsel, is not aware of any reported class action having been
brought in a Cayman Islands court. Derivative actions have been brought in the Cayman Islands courts, and the Cayman Islands courts have
confirmed the availability for such actions. In most cases, we will be the proper plaintiff in any claim based on a breach of duty owed
to us, and a claim against (for example) our officers or directors usually may not be brought by a shareholder. However, based both on
Cayman Islands authorities and on English authorities, which would in all likelihood be of persuasive authority and be applied by a court
in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:

 

	 	●	a
    company is acting, or proposing to act, illegally or beyond the scope of its authority;
	 	 	 
	 	●	the
                                            act complained of, although not beyond the scope of the authority, could be effected if duly
                                            authorized by

    more
    than the number of votes which have actually been obtained; or

	 	 	 
	 	●	those
    who control the company are perpetrating a “fraud on the minority.”

 

A
shareholder may have a direct right of action against us where the individual rights of that shareholder have been infringed or are about
to be infringed.

 

Enforcement
of Civil Liabilities. The Cayman Islands has a different body of securities laws as compared to the United States and provides
less protection to investors. Additionally, Cayman Islands companies may not have standing to sue before the federal courts of the United
States.

 

    	8

     

    

 

We
have been advised by Maples and Calder (Cayman) LLP, our Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely
(i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the
federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities
against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as
the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in
the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign
money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a
competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain
conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a
liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the
same matter, impeachable on the grounds of fraud or obtained in a manner, and or be of a kind the enforcement of which is, contrary to
natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to
public policy). A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

 

Special
Considerations for Exempted Companies. We are an exempted company with limited liability under the Companies Act. The Companies
Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but
conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted
company are essentially the same as for an ordinary company except for the exemptions and privileges listed below:

 

	 	●	an
    exempted company does not have to file an annual return of its shareholders with the Registrar of Companies;
	 	 	 
	 	●	an
    exempted company’s register of members is not open to inspection;
	 	 	 
	 	●	an
    exempted company does not have to hold an annual general meeting;
	 	 	 
	 	●	an
    exempted company may issue shares with no par value;
	 	 	 
	 	●	an
                                            exempted company may obtain an undertaking against the imposition of any future taxation)

    (such
    undertakings are usually given for 20 years in the first instance);

	 	 	 
	 	●	an
                                            exempted company may register by way of continuation in another jurisdiction and be deregistered

    in
    the Cayman Islands;

	 	 	 
	 	●	an
    exempted company may register as a limited duration company; and
	 	 	 
	 	●	an
    exempted company may register as a segregated portfolio company.

 

“Limited
liability” means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the
company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper
purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).

 

Our
Amended and Restated Memorandum and Articles of Association

 

Our
amended and restated memorandum and articles of association contain certain requirements and restrictions relating to our initial public
offering that will apply to us until the completion of our initial business combination. These provisions cannot be amended without a
special resolution. As a matter of Cayman Islands law, a resolution is deemed to be a special resolution where it has been approved by
either (i) at least two-thirds (or any higher threshold specified in a company’s articles of association) of a company’s
shareholders who, as being entitled to do so, attend and vote in person or, where proxies are allowed, by proxy at a general meeting
for which notice specifying the intention to propose the resolution as a special resolution has been given; or (ii) if so authorized
by a company’s articles of association, by a unanimous written resolution of all of the company’s shareholders. Our amended
and restated memorandum and articles of association provide that special resolutions must be approved either by at least holders of two-thirds
of the issued shares who as being entitled to do so, attend and vote in person or, where proxies are allowed, by proxy attend and vote
at a general meeting for which notice specifying the intention to propose the resolution as a special resolution has been given (i.e.,
the lowest threshold permissible under Cayman Islands law), or by a unanimous written resolution of all of our shareholders.

 

    	9

     

    

 

Our
sponsor and its affiliates will participate in any vote to amend our amended and restated memorandum and articles of association and
will have the discretion to vote in any manner they choose. Specifically, our amended and restated memorandum and articles of association
provide, among other things, that:

 

	●	if
                                            we are unable to complete our initial business combination within 18 months from the closing
                                            of our initial public offering, we will (i) cease all operations except for the purpose of
                                            winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
                                            subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share
                                            price, payable in cash, equal to the aggregate amount then on deposit in the trust account,
                                            including interest (which interest shall be net of taxes payable and less up to $100,000
                                            of interest to pay dissolution expenses) divided by the number of then issued and outstanding
                                            public shares, which redemption will completely extinguish public shareholders’ rights
                                            as shareholders (including the right to receive further liquidation distributions, if any),
                                            subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
                                            subject to the approval of our remaining shareholders and our board of directors, liquidate
                                            and dissolve;

    

	 	 
	●	prior
    to our initial business combination, we may not issue additional ordinary shares that would entitle the holders thereof to (i) receive
    funds from the trust account or (ii) vote on any initial business combination;
	 	 
	●	although
    we do not intend to enter into a business combination with a target business that is affiliated with our sponsor, our directors or
    our officers, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent
    directors, will obtain an opinion from an independent investment banking firm or another independent firm that commonly renders valuation
    opinions for the type of company we are seeking to acquire or an independent accounting firm, that such a business combination is
    fair to our company from a financial point of view;
	 	 
	●	if
                                            a shareholder vote on our initial business combination is not required by law and we do not
                                            decide to hold a shareholder vote for business or other legal reasons, we will offer to redeem
                                            our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will
                                            file tender offer documents with the Securities and Exchange Commission (the “SEC”)
                                            prior to completing our initial business combination which contain substantially the same
                                            financial and other information about our initial business combination and the redemption
                                            rights as is required under Regulation 14A of the Exchange Act;

    

	 	 
	●	so
                                            long as we obtain and maintain a listing for our securities on the Nasdaq, Nasdaq rules require
                                            that our initial business combination must occur with one or more target businesses that
                                            together have an aggregate fair market value of at least 80% of the assets held in the trust
                                            account (excluding taxes payable on the income earned on the trust account) at the time of
                                            our signing a definitive agreement in connection with our initial business combination;

    

	 	 
	●	if
                                            our shareholders approve an amendment to our amended and restated memorandum and articles
                                            of association that would (i) modify the substance or timing of our obligation to allow redemption
                                            in connection with our initial business combination or to redeem our public shares if we
                                            do not complete our initial business combination within 18 months from the closing of our
                                            initial public offering or (ii) modify other provisions relating to shareholders’ rights
                                            or pre-business combination activity, we will provide our public shareholders with the opportunity
                                            to redeem all or a portion of their ordinary shares upon such approval at a per-share price,
                                            payable in cash, equal to the aggregate amount then on deposit in the trust account, including
                                            accrued interest (which interest shall be net of taxes payable) divided by the number of
                                            then issued and outstanding public shares; and

    

	 	 
	●	we
    will not effectuate our initial business combination with another blank check company or a similar company with nominal operations.

 

In
addition, our amended and restated memorandum and articles of association will provide that under no circumstances will we redeem our
public shares in an amount that would cause our net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation
of our initial business combination.

 

The
Companies Act permits a company incorporated in the Cayman Islands to amend its memorandum and articles of association with the approval
of the holders of at least two-thirds of such company’s issued and outstanding shares present (in person or via proxy) and voting
at a general meeting. A company’s articles of association may specify that the approval of a higher majority is required but, provided
the approval of the required majority is obtained, any Cayman Islands exempted company may amend its memorandum and articles of association
regardless of whether its memorandum and articles of association provides otherwise. Accordingly, with the requisite shareholder approval,
we could amend any of the provisions relating to our proposed offering, structure and business plan which are contained in our amended
and restated memorandum and articles of association. Nevertheless, we view all of these provisions as binding obligations to our shareholders
and neither we, nor our officers or directors, will take any action to amend or waive any of these provisions unless we provide dissenting
public shareholders with the opportunity to redeem their public shares.

 

    	10

     

    

 

Anti-money
laundering — Cayman Islands

 

If
any person in the Cayman Islands knows or suspects or has reasonable grounds for knowing or suspecting that another person is engaged
in criminal conduct or money laundering or is involved with terrorism or terrorist financing and property and the information for that
knowledge or suspicion came to their attention in the course of business in the regulated sector, or other trade, profession, business
or employment, the person is required to report such knowledge or suspicion to (i) the Financial Reporting Authority, or FRA, of the
Cayman Islands, pursuant to the Proceeds of Crime Act (As Revised) of the Cayman Islands if the disclosure relates to criminal conduct
or money laundering, or (ii) a police officer of the rank of constable or higher, or the FRA, pursuant to the Terrorism Act (As Revised)
of the Cayman Islands, if the disclosure relates to involvement with terrorism or terrorist financing and property. Such a report shall
not be treated as a breach of confidence or of any restriction upon the disclosure of information imposed by any enactment or otherwise.

 

Cayman
Islands Data Protection

 

We
have certain duties under the Data Protection Act (As Revised) of the Cayman Islands, or the DPA, based on internationally accepted principles
of data privacy.

 

Privacy
Notice

 

Introduction

 

This
privacy notice puts our shareholders on notice that through your investment in the company you will provide us with certain personal
information which constitutes personal data within the meaning of the DPA (“personal data”).

 

In
the following discussion, the “company” refers to us and our affiliates and/or delegates, except where the context requires
otherwise.

 

Investor
Data

 

We
will collect, use, disclose, retain and secure personal data to the extent reasonably required only and within the parameters that could
be reasonably expected during the normal course of business. We will only process, disclose, transfer or retain personal data to the
extent legitimately required to conduct our activities of on an ongoing basis or to comply with legal and regulatory obligations to which
we are subject. We will only transfer personal data in accordance with the requirements of the DPA, and will apply appropriate technical
and organizational information security measures designed to protect against unauthorized or unlawful processing of the personal data
and against the accidental loss, destruction or damage to the personal data.

 

In
our use of this personal data, we will be characterized as a “data controller” for the purposes of the DPA, while our affiliates
and service providers who may receive this personal data from us in the conduct of our activities may either act as our “data processors”
for the purposes of the DPA or may process personal information for their own lawful purposes in connection with services provided to
us.

 

We
may also obtain personal data from other public sources. Personal data includes, without limitation, the following information relating
to a shareholder and/or any individuals connected with a shareholder as an investor: name, residential address, email address, contact
details, corporate contact information, signature, nationality, place of birth, date of birth, tax identification, credit history, correspondence
records, passport number, bank account details, source of funds details and details relating to the shareholder’s investment activity.

 

Who
this Affects

 

If
you are a natural person, this will affect you directly. If you are a corporate investor (including, for these purposes, legal arrangements
such as trusts or exempted limited partnerships) that provides us with personal data on individuals connected to you for any reason in
relation your investment in the Company, this will be relevant for those individuals and you should transmit the content of this Privacy
Notice to such individuals or otherwise advise them of its content.

 

    	11

     

    

 

How
the Company May Use Your Personal Data

 

The
company, as the data controller, may collect, store and use personal data for lawful purposes, including, in particular:

 

(i)
where this is necessary for the performance of our rights and obligations under any purchase agreements;

 

(ii)
where this is necessary for compliance with a legal and regulatory obligation to which we are subject (such as compliance with anti-money
laundering and FATCA/CRS requirements); and/or

 

(iii)
where this is necessary for the purposes of our legitimate interests and such interests are not overridden by your interests, fundamental
rights or freedoms.

 

Should
we wish to use personal data for other specific purposes (including, if applicable, any purpose that requires your consent), we will
contact you.

 

Why
We May Transfer Your Personal Data

 

In
certain circumstances, we may be legally obliged to share personal data and other information with respect to your shareholding with
the relevant regulatory authorities such as the Cayman Islands Monetary Authority or the Tax Information Authority. They, in turn, may
exchange this information with foreign authorities, including tax authorities.

 

We
anticipate disclosing personal data to persons who provide services to us and their respective affiliates (which may include certain
entities located outside the US, the Cayman Islands or the European Economic Area), who will process your personal data on our behalf.

 

The
Data Protection Measures We Take

 

Any
transfer of personal data by us or our duly authorized affiliates and/or delegates outside of the Cayman Islands shall be in accordance
with the requirements of the DPA.

 

We
and our duly authorized affiliates and/or delegates shall apply appropriate technical and organizational information security measures
designed to protect against unauthorized or unlawful processing of personal data, and against accidental loss or destruction of, or damage
to, personal data.

 

We
shall notify you of any personal data breach that is reasonably likely to result in a risk to your interests, fundamental rights or freedoms
or those data subjects to whom the relevant personal data relates.

 

Certain
Anti-Takeover Provisions of Our Amended and Restated Memorandum and Articles of Association

 

Our
authorized but unissued Class A ordinary shares and preferred shares are available for future issuances without shareholder approval
and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee
benefit plans. The existence of authorized but unissued and unreserved Class A ordinary shares and preferred shares could render more
difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

 

Shares
Eligible for Future Sale

 

The
Class A ordinary shares sold in in our initial public offering are freely tradable without restriction or further registration under
the Securities Act, except for any shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act.
The founders shares and EBC founder shares are restricted securities under Rule 144, in that they were issued in private transactions
not involving a public offering, and are subject to transfer restrictions as set forth elsewhere in this Exhibit.

 

Rule
144

 

A
person who has beneficially owned restricted Class A ordinary shares or warrants for at least six months would be entitled to sell their
securities provided that (i) such person is not deemed to have been one of our affiliates at the time of, or at any time during the three
months preceding, a sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at least three months before
the sale. Persons who have beneficially owned restricted Class A ordinary shares for at least six months but who are our affiliates at
the time of, or any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person
would be entitled to sell within any three-month period a number of shares that does not exceed the greater of either of the following:

 

	 	●	1%
    of the total number of ordinary shares then issued and outstanding on an as converted basis; or
	 	 	 
	 	●	the
    average weekly trading volume of the Class A ordinary shares during the four calendar weeks preceding the filing of a notice on Form
    144 with respect to the sale.

 

    	12

     

    

 

Sales
under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information
about us.

 

Restrictions
on the Use of Rule 144 by Shell Companies or Former Shell Companies

 

Historically,
the SEC staff had taken the position that Rule 144 is not available for the resale of securities initially issued by companies that are,
or previously were, blank check companies, like us. The SEC has codified and expanded this position by prohibiting the use of Rule 144
for resale of securities issued by any shell companies (other than business combination related shell companies) or any issuer that has
been at any time previously a shell company. The SEC has provided an important exception to this prohibition, however, if the following
conditions are met:

 

	 	●
    	the
    issuer of the securities that was formerly a shell company has ceased to be a shell company;
	 	 	 
	 	●	the
issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
	 	 	 
	 	●	the
issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12
months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K;
and
	 	 	 
	 	●	at
least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as
an entity that is not a shell company.

 

As
a result, our sponsor will be able to sell its founders shares and private warrants and EarlyBirdCapital will be able to sell its EBC
founder shares pursuant to Rule 144 without registration one year after we have completed our initial business combination.

 

Registration
Rights

 

The
holders of the founders shares, private warrants, EBC founder shares and warrants that may be issued on conversion of working capital
loans (and any ordinary shares issuable upon the exercise of the private warrants or warrants issued upon conversion of the working capital
loans and upon conversion of the founders shares), will be entitled to registration rights pursuant to an agreement signed prior to our
initial public offering. The holders of a majority of these securities are entitled to make up to two demands that we register such securities.
The holders of the majority of the founders shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these Class B ordinary shares are to be released from their transfer restrictions. The holders of a majority
of the EBC founder shares, private warrants and warrants issued to our sponsor, officers, directors or their affiliates in payment of
working capital loans made to us (or underlying securities) can elect to exercise these registration rights at any time after we consummate
a business combination. Notwithstanding anything to the contrary, EarlyBirdCapital and its designees may only make a demand on one occasion
and only during the five-year period beginning on the effective date of the registration statement for our initial public offering. In
addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to our consummation of a business combination; provided, however, that EarlyBirdCapital and its designees may participate in a “piggy-back”
registration only during the seven-year period beginning on the effective date of the registration statement for our initial public offering.
We will bear the expenses incurred in connection with the filing of any such registration statements.

 

Listing
of Securities

 

Our
units, Class A ordinary shares and warrants are listed on Nasdaq under the symbols “FNVTU”, “FNVT” and “FNVTW”,
respectively.

 

    	13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]